Paradromics
PrivateLast Round
Strategic
Feb 12, 2025
Total Funding Raised
$84.1M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Paradromics is a neurotechnology company that develops advanced brain-computer interface technology to enhance data transmission rates between the brain and machines, facilitating high-volume, bidirectional data streaming for patients with neurological disorders.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Clinical Trials, Health IoT
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Paradromics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Paradromics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Feb 12, 2025 | ||||
| Series A | May 18, 2023 | ||||
| Grant | Oct 14, 2021 | ||||
| Seed | Jul 22, 2021 | ||||
| Seed | Jun 11, 2018 | ||||
Grant | Jul 10, 2017 |
Key People
Founding team and executive leadership
Paradromics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Loup Funds | Seed |
| National Institute of Mental Health | Grant |
| Fusion Fund | Seed |
| Dolby Family Ventures | Seed, Strategic, Series A |
| IT-Farm Corporation | Seed, Strategic |
| NIH RADx | Grant |
| Tech-Synergy | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 18, 2026
Launched an academic collaboration programme to advance BCI technology.
- Jan 1, 2026
Connexus BCI, a brain-computer interface for paralysis patients, is in development.
Paradromics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Paradromics's valuation, stock price, and market status.